The treatment landscape for hemophilia A and B is expanding with strategies and therapies to optimize efficacy, provide durable hemostasis restoration, and improve safety. These contemporary approaches to care have also led to new pathways and assays for clinical and laboratory monitoring. In this CME Outfitters Webcast, an interdisciplinary faculty, including a renowned patient advocate who has lived with hemophilia for many years, discuss the impact of key advances in treatment and monitoring on quality of care and outcomes. A focused segment on shared decision-making keeps the conversation grounded in counseling and collaboration and includes both clinician and patient perspectives.
- Provider:CME Outfitters, LLC
- Activity Link: https://www.cmeoutfitters.com/activity/hemostasis-2-0-rethinking-hemophilia-management-and-monitoring-with-anti-tfpis-and-fviii-mimetics-3/
- Start Date: 2024-04-15 05:00:00
- End Date: 2024-04-15 05:00:00
- Credit Details: IPCE Credits: 1.0 hours
AAPA Category 1 Credit™️: 1.0 hours
AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours - MOC Credit Details: ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: Novo Nordisk (Any division) - Amount: 0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Hematology, Internal Medicine
Subscribe
Login
0 Comments
Oldest